Cookie Consent by Free Privacy Policy Generator Update cookies preferences

Session 23

OESO-SEMPIRE 16th World Conference | Esophagus 2024 | Strasbourg | April 23-26, 2024 | Venue: IRCAD France

<  back to Program at a glance
<  back to all the scientific sessions


Session 23: Esophageal Cancer: Adenocarcinoma

Thursday, April 25, 4:00 – 5:30 pm
Auditorium Kagame‚Äč

Introduction: Arnulf Hölscher (Germany)
«In memoriam Professor Dr. Jörg Rüdiger Siewert – Vita and SIEWERT classification»
Chairs: Stefan P. Mönig (Switzerland) – Giovanni de Manzoni (Italy)
Moderators: Arnulf Hölscher (Germany) – Bruno Zilberstein (Brazil) – Edward Cheong Chee Keong (Singapore) – Marc van Berge Hennegouwen (Netherlands) 
  1. Decision making in Siewert II Adenocarcinoma: gastrectomy versus esophagectomy? – Stefan P. Mönig (Switzerland)
  2. Is thoracic duct resection indicated in adenocarcinoma of the esophagus? – Paolo Morgagni (Italy)
  3. Lymph node dissection of the upper mediastinum – indicated in all patients? – Paul M. Schneider (Switzerland)
  4. Which is the evidence-based surgical approach: transhiatal, left thoracoabdominal, two-stage transthoracic or three-stage transthoracic for distal esophageal adenocarcinoma? – Andrew Davis (UK)
  5. F Is cT1 still a surgical disease, and in which cases? – Maria Bencivenga (Italy)
  6. What is the best way to treat anastomotic leakage: intrathoracic anastomosis? – Marc van Berge Hennegouwen (Netherlands)